<DOC>
	<DOCNO>NCT00208377</DOCNO>
	<brief_summary>The purpose study monitor performance determine metal ion release DePuy ASR™ System treatment patient hip joint disease require hip resurface surgery . Patients enter study evaluate regular interval follow hip surgery use patient , clinical x-ray assessment . A subset patient also blood sample take regular interval allow metal ion level determine undergo scan allow bone mineral density bone surround implant monitor . DePuy decide close Study 4Q 2009 . The Study terminate effect December 2010 allow completion 5 year follow assessment . Please note subsequent decision DePuy voluntarily recall ASR product 24 August 2010 . Additional information regard voluntary recall follow-up patient affect recall find follow link http : //www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON079157 http : //www.depuy.com/countries_list .</brief_summary>
	<brief_title>A Multi-centre Study Assess Long-term Performance DePuy ASR™ System Primary Hip Resurfacing Surgery</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Femoral Fractures</mesh_term>
	<mesh_term>Hip Dislocation</mesh_term>
	<mesh_term>Hip Dislocation , Congenital</mesh_term>
	<mesh_term>Slipped Capital Femoral Epiphyses</mesh_term>
	<mesh_term>Collagen Diseases</mesh_term>
	<mesh_term>Rheumatic Diseases</mesh_term>
	<criteria>) Male female subject , age 18 65 year inclusive . ii ) Subjects current indication standard metalonmetal ( MoM ) hip resurface arthroplasty suitable cementless fixation acetabulum . These include pain , deformity , loss function , responsive medical treatment . iii ) Subjects able give voluntary , write informed consent participate investigation consent obtain . iv ) Subjects , , opinion Investigator , able understand investigation , cooperate investigational procedure , willing return hospital require postoperative followup . ) Subjects , opinion Investigator , exist condition would compromise participation followup study . ii ) Subjects proven significant osteoporosis poor bone quality . iii ) Subjects compromised renal function . iv ) Subjects proven metal sensitivity . v ) Subjects infectious , highly communicable disease , may limit followup i.e . active tuberculosis , hepatitis , immunocompromised condition , etc . vi ) Women pregnant . vii ) Subjects know drug alcohol abuser psychological disorder could affect followup care treatment outcomes . viii ) Subjects participated clinical study investigational product last 6 month ( ) . ix ) Subjects currently , last 12 month , participate clinical study involve exposure ionise radiation . x ) Subjects currently involved injury litigation claim .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Hip</keyword>
	<keyword>Conservative</keyword>
	<keyword>Metal-on-Metal</keyword>
	<keyword>Resurfacing</keyword>
</DOC>